Letermovir Prophylaxis for Cytyomegalovirus in Hematopoietic-Cell Transplantation
In: The New England Journal of Medicine, Jg. 377 (2017-12-21), Heft 25, S. 2433-2444
academicJournal
Zugriff:
The study aims to evaluate the efficacy and safety of letermovir prophylaxis as a form of treatment for patients with cytyomegalovirus (CMV) in hematopoietic-cell transplantation. The results indicate that among these patients, letermovir prophylaxis resulted in a significantly lower risk of CMV infection.
Titel: |
Letermovir Prophylaxis for Cytyomegalovirus in Hematopoietic-Cell Transplantation
|
---|---|
Autor/in / Beteiligte Person: | Marty, F. M. ; Ljungman, P. |
Zeitschrift: | The New England Journal of Medicine, Jg. 377 (2017-12-21), Heft 25, S. 2433-2444 |
Veröffentlichung: | 2017 |
Medientyp: | academicJournal |
ISSN: | 0028-4793 (print) |
Schlagwort: |
|
Sonstiges: |
|